Brand: ZEPZELCA. API: lurbinectedin is used to treat adults with small cell lung cancer (SCLC).
Zepzelca (generic name: lurbinectedin) is a prescription chemotherapy medication used exclusively to treat adults with small cell lung cancer (SCLC).
| Brand Name: | ZEPZELCA – On Request |
| Generic Name: | lurbinectedin |
| Strength: | For injection: 4 mg lyophilized powder in a single-dose vial. |
| Manufacturer: | Jazz Pharmaceuticals, Inc. |
| Approved By: | EMA, USFDA |
| Get access to medicines: | In India |
| Price: | On Request |
See full prescribing information for ZEPZELCA: Patient Information
Get access ZEPZELCA to treat adults with small cell lung cancer (SCLC) on a Named Patient Import Basis.
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ZEPZELCA (lurbinectedin) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
